Citigroup Maintains Buy on Herbalife, Lowers Price Target to $17
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
Citigroup analyst Chasen Bender maintains Herbalife (NYSE:HLF) with a Buy and lowers the price target from $21 to $17.
Citigroup analyst Chasen Bender maintains Herbalife (NYSE:HLF) with a Buy and lowers the price target from $21 to $17.